Cite
lncRNA CYTOR promotes lung adenocarcinoma gemcitabine resistance and epithelial-mesenchymal transition by sponging miR-125a-5p and upregulating ANLN and RRM2
MLA
Cao Qijun, et al. “LncRNA CYTOR Promotes Lung Adenocarcinoma Gemcitabine Resistance and Epithelial-Mesenchymal Transition by Sponging MiR-125a-5p and Upregulating ANLN and RRM2.” Acta Biochimica et Biophysica Sinica, vol. 56, Jan. 2024, pp. 210–22. EBSCOhost, https://doi.org/10.3724/abbs.2023287.
APA
Cao Qijun, Wang Haixia, Zhu Jialong, Qi Chen, Huang Hairong, & Chu Xiaoyuan. (2024). lncRNA CYTOR promotes lung adenocarcinoma gemcitabine resistance and epithelial-mesenchymal transition by sponging miR-125a-5p and upregulating ANLN and RRM2. Acta Biochimica et Biophysica Sinica, 56, 210–222. https://doi.org/10.3724/abbs.2023287
Chicago
Cao Qijun, Wang Haixia, Zhu Jialong, Qi Chen, Huang Hairong, and Chu Xiaoyuan. 2024. “LncRNA CYTOR Promotes Lung Adenocarcinoma Gemcitabine Resistance and Epithelial-Mesenchymal Transition by Sponging MiR-125a-5p and Upregulating ANLN and RRM2.” Acta Biochimica et Biophysica Sinica 56 (January): 210–22. doi:10.3724/abbs.2023287.